Preferred Label : Gefitinib;

MeSH definition : A selective tyrosine kinase inhibitor for the EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) that is used for the treatment of locally advanced or metastatic NON-SMALL CELL LUNG CANCER.;

MeSH synonym : N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamide;

MeSH hyponym : ZD 1839;

UNII : S65743JHBS;

Details


Main resources

You can consult :

A selective tyrosine kinase inhibitor for the EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) that is used for the treatment of locally advanced or metastatic NON-SMALL CELL LUNG CANCER.

https://www.ema.europa.eu/en/medicines/human/EPAR/gefitinib-mylan
2018
false
United Kingdom
French
English
syndication feed
drug interactions
pregnancy
breast feeding
antineoplastic agents
antineoplastic agents
quinazolines
protein kinase inhibitors
drug approval
treatment outcome
administration, oral
adult
carcinoma, non-small-cell lung
neoplasm metastasis
protein kinase inhibitors
quinazolines
drugs, generic
carcinoma, non-small-cell lung
mutation
Tyrosine Kinase Inhibitors
gefitinib
package leaflet
drug evaluation
summary of product characteristics
ErbB Receptors
Gefitinib
Gefitinib

---
http://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Medicaments-ciblant-EGFR-erlotinib-gefitinib-afatinib
2016
false
false
false
France
French
guidelines for drug use
patients guideline
practice guideline
antineoplastic agents
antineoplastic agents
antineoplastic agents
administration, oral
Erlotinib Hydrochloride
Erlotinib Hydrochloride
Erlotinib Hydrochloride
erlotinib
protein kinase inhibitors
protein kinase inhibitors
protein kinase inhibitors
Drug-Related side effects and adverse reactions
continuity of patient care
drug monitoring
drug interactions
pregnancy
carcinoma, non-small-cell lung
interdisciplinary communication
afatinib
afatinib
afatinib
afatinib
gefitinib
Tyrosine Kinase Inhibitors
quinazolines
quinazolines
quinazolines
ErbB Receptors
Gefitinib
Gefitinib
Gefitinib
Afatinib
Afatinib
Afatinib

---
http://www.pharmactuel.com/index.php/pharmactuel/article/view/942
2014
false
Canada
French
lung neoplasms
carcinoma, non-small-cell lung
journal article
lung neoplasms
carcinoma, non-small-cell lung
lung neoplasms
carcinoma, non-small-cell lung
antineoplastic agents
antibodies, monoclonal, humanized
angiogenesis inhibitors
protein kinase inhibitors
pyrazoles
pyridines
Erlotinib Hydrochloride
Pemetrexed
Bevacizumab
Gefitinib
Crizotinib

---
https://www.ema.europa.eu/medicines/human/EPAR/Iressa
2012
false
United Kingdom
French
English
syndication feed
drug interactions
pregnancy
breast feeding
drug screening assays, antitumor
antineoplastic agents
antineoplastic agents
quinazolines
protein kinase inhibitors
drug approval
treatment outcome
tablets
administration, oral
adult
carcinoma, non-small-cell lung
neoplasm metastasis
protein kinase inhibitors
quinazolines
Tyrosine Kinase Inhibitors
gefitinib
quinazolines
package leaflet
drug evaluation
summary of product characteristics
ErbB Receptors
Gefitinib
Gefitinib

---
https://www.inesss.qc.ca/fileadmin/doc/INESSS/Inscription_medicaments/Avis_au_ministre/ProjetPilote_Cancer/Document_synthese_final_CAV.pdf
2011
false
Canada
French
Pemetrexed
Erlotinib Hydrochloride
Everolimus
drug evaluation
drug evaluation
antineoplastic agents
Cost-Benefit analysis
treatment outcome
insurance, health, reimbursement
carcinoma, renal cell
neoplasm metastasis
pemetrexed
lung neoplasms
canada
gefitinib
everolimus
erlotinib
survival analysis
technical report
drug information
Gefitinib

---
http://www.meddispar.fr/medicaments/3959507
2010
false
France
French
tablets
administration, oral
gefitinib
drug prescriptions
legislation, drug
antineoplastic agents
quinazolines
drug information
Gefitinib

---
http://www.has-sante.fr/portail/jcms/c_938991/iressa-gefitinib-inhibiteur-de-la-tyrosine-kinase
http://www.has-sante.fr/portail/jcms/c_938990/synthese-d-avis-iressa-ct-6839
http://www.has-sante.fr/portail/jcms/c_883286/iressa
2009
false
France
French
antineoplastic agents
protein kinase inhibitors
quinazolines
gefitinib
carcinoma, non-small-cell lung
insurance, health, reimbursement
adult
neoplasm metastasis
treatment outcome
survival analysis
evaluation of the transparency committee
guidelines for drug use
Gefitinib

---
https://www.cadth.ca/sites/default/files/pdf/278_gefitinib_cetap_f.pdf
2004
Canada
French
lung neoplasms
bronchial neoplasms
lung neoplasms
lung neoplasms
bronchial neoplasms
bronchial neoplasms
carcinoma, non-small-cell lung
antineoplastic agents
quinazolines
neoplasm metastasis
protein-tyrosine kinases
survival rate
canada
carcinoma, non-small-cell lung
carcinoma, non-small-cell lung
treatment outcome
antineoplastic agents
quinazolines
antineoplastic agents
quinazolines
clinical trials as topic
quinazolines
antineoplastic agents
enzyme inhibitors
enzyme inhibitors
enzyme inhibitors
enzyme inhibitors
Tyrosine Kinase Inhibitors
quinazolines
evaluation studies
journal article
table
Gefitinib

---
Nous contacter.
19/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.